Los Angeles Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.2M | Sell |
1,112,386
-355,397
| -24% | -$9.46M | 0.12% | 142 |
|
|
2025
Q4 | $35.7M | Buy |
1,467,783
+109,881
| +8% | +$2.77M | 0.12% | 128 |
|
|
2025
Q3 | $34.6M | Buy |
1,357,902
+1,219,535
| +881% | +$30.1M | 0.12% | 134 |
|
|
2025
Q2 | $3.35M | Sell |
138,367
-2,395,952
| -95% | -$55.9M | 0.01% | 365 |
|
|
2025
Q1 | $64.2M | Buy |
2,534,319
+2,504,816
| +8,490% | +$65.5M | 0.28% | 72 |
|
|
2024
Q4 | $783K | Sell |
29,503
-2,854,990
| -99% | -$77.4M | ﹤0.01% | 694 |
|
|
2024
Q3 | $83.5M | Buy |
2,884,493
+985,058
| +52% | +$28.7M | 0.34% | 67 |
|
|
2024
Q2 | $53.1M | Buy |
1,899,435
+1,851,772
| +3,885% | +$51M | 0.19% | 101 |
|
|
2024
Q1 | $1.32M | Buy |
47,663
+17,799
| +60% | +$494K | ﹤0.01% | 604 |
|
|
2023
Q4 | $860K | Buy |
29,864
+899
| +3% | +$27.2K | ﹤0.01% | 724 |
|
|
2023
Q3 | $961K | Sell |
28,965
-343
| -1% | -$12.1K | ﹤0.01% | 655 |
|
|
2023
Q2 | $1.08M | Sell |
29,308
-420,804
| -93% | -$16.4M | ﹤0.01% | 640 |
|
|
2023
Q1 | $18.4M | Sell |
450,112
-4,543,468
| -91% | -$196M | 0.08% | 210 |
|
|
2022
Q4 | $256M | Sell |
4,993,580
-9,646
| -0.2% | -$462K | 1.24% | 8 |
|
|
2022
Q3 | $219M | Sell |
5,003,226
-2,478,013
| -33% | -$120M | 1.14% | 11 |
|
|
2022
Q2 | $392M | Sell |
7,481,239
-718,965
| -9% | -$36.6M | 1.93% | 6 |
|
|
2022
Q1 | $425M | Buy |
8,200,204
+7,505,371
| +1,080% | +$389M | 1.67% | 8 |
|
|
2021
Q4 | $41M | Buy |
694,833
+201,879
| +41% | +$10M | 0.15% | 127 |
|
|
2021
Q3 | $21.2M | Sell |
492,954
-639,982
| -56% | -$28.4M | 0.1% | 184 |
|
|
2021
Q2 | $44.4M | Buy |
1,132,936
+413,816
| +58% | +$16.1M | 0.2% | 116 |
|
|
2021
Q1 | $26.1M | Buy |
719,120
+88,403
| +14% | +$3.14M | 0.12% | 181 |
|
|
2020
Q4 | $23.2M | Sell |
630,717
-263,771
| -29% | -$9.68M | 0.1% | 184 |
|
|
2020
Q3 | $31.1M | Sell |
894,488
-307,272
| -26% | -$10.8M | 0.14% | 128 |
|
|
2020
Q2 | $37.3M | Sell |
1,201,760
-11,574
| -1% | -$393K | 0.18% | 126 |
|
|
2020
Q1 | $37.6M | Buy |
1,213,334
+92,809
| +8% | +$3.16M | 0.24% | 101 |
|
|
2019
Q4 | $41.7M | Buy |
1,120,525
+259,334
| +30% | +$9.24M | 0.21% | 116 |
|
|
2019
Q3 | $29.4M | Sell |
861,191
-580,208
| -40% | -$21.1M | 0.16% | 137 |
|
|
2019
Q2 | $59.2M | Buy |
1,441,399
+209,350
| +17% | +$8.31M | 0.32% | 76 |
|
|
2019
Q1 | $49.6M | Sell |
1,232,049
-115,223
| -9% | -$4.61M | 0.28% | 89 |
|
|
2018
Q4 | $55.8M | Buy |
1,347,272
+16,774
| +1% | +$696K | 0.35% | 73 |
|
|
2018
Q3 | $55.6M | Sell |
1,330,498
-38,155
| -3% | -$1.47M | 0.29% | 84 |
|
|
2018
Q2 | $47.1M | Sell |
1,368,653
-330,291
| -19% | -$11.3M | 0.26% | 92 |
|
|
2018
Q1 | $57.2M | Sell |
1,698,944
-307,046
| -15% | -$10.6M | 0.32% | 76 |
|
|
2017
Q4 | $68.9M | Sell |
2,005,990
-376,208
| -16% | -$12.8M | 0.38% | 63 |
|
|
2017
Q3 | $80.7M | Buy |
2,382,198
+96,335
| +4% | +$3.1M | 0.47% | 42 |
|
|
2017
Q2 | $72.8M | Buy |
2,285,863
+2,230
| +0.1% | +$70.3K | 0.46% | 38 |
|
|
2017
Q1 | $74.1M | Sell |
2,283,633
-592,096
| -21% | -$18.7M | 0.54% | 35 |
|
|
2016
Q4 | $88.6M | Sell |
2,875,729
-44,869
| -2% | -$1.37M | 0.69% | 24 |
|
|
2016
Q3 | $93.9M | Sell |
2,920,598
-1,366
| -0% | -$45.7K | 0.78% | 17 |
|
|
2016
Q2 | $97.6M | Buy |
2,921,964
+831,399
| +40% | +$26.5M | 0.83% | 17 |
|
|
2016
Q1 | $58.8M | Sell |
2,090,565
-5,217
| -0.2% | -$149K | 0.52% | 44 |
|
|
2015
Q4 | $64.2M | Buy |
2,095,782
+319,272
| +18% | +$10M | 0.59% | 39 |
|
|
2015
Q3 | $52.9M | Buy |
1,776,510
+9,887
| +0.6% | +$317K | 0.52% | 40 |
|
|
2015
Q2 | $56.2M | Sell |
1,766,623
-272,733
| -13% | -$8.89M | 0.52% | 38 |
|
|
2015
Q1 | $67.3M | Sell |
2,039,356
-4,543,013
| -69% | -$144M | 0.62% | 28 |
|
|
2014
Q4 | $195M | Buy |
6,582,369
+1,979,299
| +43% | +$56.8M | 1.79% | 2 |
|
|
2014
Q3 | $129M | Sell |
4,603,070
-2,174,647
| -32% | -$61M | 1.56% | 4 |
|
|
2014
Q2 | $191M | Buy |
6,777,717
+3,869,346
| +133% | +$110M | 1.84% | 3 |
|
|
2014
Q1 | $88.6M | Buy |
2,908,371
+1,592,183
| +121% | +$47.5M | 0.97% | 8 |
|
|
2013
Q4 | $38.2M | Sell |
1,316,188
-694,497
| -35% | -$20.2M | 0.43% | 60 |
|
|
2013
Q3 | $54.8M | Sell |
2,010,685
-1,170,616
| -37% | -$31.9M | 0.68% | 23 |
|
|
2013
Q2 | $84.5M | Buy |
+3,181,301
| New | +$87.9M | 1.2% | 8 |
|
Other funds holding PFE
VCM
VPM
Los Angeles Capital Management's PFE Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Pfizer (PFE) stake by 24% in Q1 2026, selling an estimated $9.46M and leaving 1,112,386 shares worth $31.2M. The position accounts for 0.12% of the portfolio, ranked #142.
Los Angeles Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $425M in Q1 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Los Angeles Capital Management held 1,112,386 shares of Pfizer worth $31.2M as of Q1 2026.
- Los Angeles Capital Management sold 355,397 Pfizer shares in Q1 2026, an estimated $9.46M.
- Pfizer made up 0.12% of Los Angeles Capital Management's portfolio in Q1 2026, its #142 holding.
- Los Angeles Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Los Angeles Capital Management's Pfizer position peaked at $425M in Q1 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.